J4F-MC-CYAB: A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Finding Study Evaluating LY3848575 in Chronic Neuropathic Pain Associated With Distal Sensory Polyneuropathy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513435-24-01

Acronym

J4F-MC-CYAB

Enrollment

Registered

2025-05-23

Start date

2025-06-03

Completion date

Unknown

Last updated

2025-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic Pain; Distal Sensory Polyneuropathy

Brief summary

Mean Change from Baseline in Average Pain Intensity Numeric Rating Scale (API-NRS)

Interventions

DRUGPlacebo to match LY3848575

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Mean Change from Baseline in Average Pain Intensity Numeric Rating Scale (API-NRS)	—

Countries

Germany, Poland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026